Construction of phospholamban antisense RNA recombinant adeno-associated virus vector and its effects in rat cardiomyocytes

Acta Pharmacologica Sinica

Volumn 26, Issue 1, 2005, Pages 51-55

  Li, Jiang ^a   Hu, Shen Jiang ^a   Sun, Jian ^a   Zhu, Zhao Hui ^a   Zheng, Xia ^a   Wang, Guo Zhong ^a   Yao, Yu Mei ^a   Chen, Nai Yun ^a   Zhao, Xiao Yan ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Antisense RNA; Calcium; Dependovirus; Phospholamban; Sarcoplasmic reticulum calcium ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOVIRUS VECTOR; BETA GALACTOSIDASE; CALCIUM ION; COMPLEMENTARY RNA; ISOPRENALINE; PHOSPHOLAMBAN; PLASMID VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; ENZYME ACTIVITY; GENE EXPRESSION; GENE TARGETING; GENETIC CODE; GENETIC TRANSFECTION; HEART MUSCLE CELL; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DETERMINATION; RAT; RECOMBINANT PLASMID; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; SARCOPLASMIC RETICULUM; STAINING; VIRAL GENE DELIVERY SYSTEM; WESTERN BLOTTING;

ANIMALS; CALCIUM; CALCIUM-BINDING PROTEINS; CALCIUM-TRANSPORTING ATPASES; CELL LINE; DEPENDOVIRUS; EMBRYO; GENETIC VECTORS; HUMANS; KIDNEY; LAC OPERON; MYOCYTES, CARDIAC; RATS; RECOMBINANT PROTEINS; RNA, ANTISENSE; RNA, MESSENGER; SARCOPLASMIC RETICULUM CALCIUM-TRANSPORTING ATPASES;

EID: 11844305612     PISSN: 16714083     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2005.00006.x     Document Type: Article

References (15)

1. Bernecker OY, del Monte F, Hajjar RJ. Gene therapy for the treatment of heart failure-calcium signaling. Semin Thorac Cardiovasc Surg 2003; 15: 268-76.
2. Zhai J, Schmidt AG, Hoit BD, Kimura Y, MacLennan DH, Kranias EG. Cardiac-specific overexpression of a superinhibitory pentameric phospholamban mutant enhances inhibition of cardiac function in vivo. J Biol Chem 2000; 275(14): 10538-44.
3. Koss KL, Grupp IL, Kranias EG. The relative phospholamban and SERCA2 ratio: a critical determinant of myocardial contractility. Basic Res Cardiol 1997; 92 (Suppl 1): 17-24.
4. Luo W, Grupp IL, Harrer J, Ponniah S, Grupp G, Duffy JJ, et al. Targeted ablation of the phospholamban gene is associated with markedly enhanced myocardial contractility and loss of β-agonist stimulation. Circ Res 1994; 75: 401-9.
5. Kadambi VJ, Ponniah S, Harrer JM, Hoit BD, Dorn GW, Walsh RA, et al. Cardiac-specific overexpression of phospholamban alters calcium kinetics and resultant cardiomyocytes mechanics in transgenic mice. J Clin Invest 1996; 97: 533-9.
6. 2+-ATPase activity and cardiac myocyte contractility. Circulation 1999; 100: 974-80.
7. Monte F, Harding SE, Dec GW, Gwathmey JK, Hajjar RJ. Targeting phospholamban by gene transfer in human heart failure. Circulation 2002; 105: 904-7.
8. Clark KP, Voulgaropoulou F, Johnson P R. A stable cell line carrying adenovirus-inducible rep and cap genes allow for infectivity titration of adeno-associated virus vectors. Gene Ther 1996; 3: 1124-32.
9. Zhang YB, Leng XS, Peng JR, He XJ, LU JF, Weng SG, et al. Construction, packaging, and titration of recombinant adeno-association virus vectors contaning antitumor genes. Natl Med J China 2002; 82: 564-7.
10. Svensson EC, Marshall DJ, Woodard K, Lin H, Jing F, Chu L, et al. Efficient and stable transduction of cardiomyocytes after intramyocardiol injection or intracoronary perfusion with recombinant adeno-associated virus vectors. Circulation 1999; 99: 201-5.
11. 2+-dependent pNPPase age-dependent changes. Basic Res Cardiol 1995; 90: 323-31.
12. i mobilization by KCl, norepinephrine, and caffeine in newborn rat cardiomyocytes. Acta Pharmacol Sin 1999; 20: 292-6.
13. Brittsan AG, Kranias EG. Phospholamban and cardiac contractile function. J Mol Cell Cardiol 2000; 32: 2131-9.
14. Teramoto S, Ishii T, Matsuse T, Fukuchi Y. Recombinant adeno-associated virus vectors efficiently transduce foreign gene into bovine aortic endothelial cell: comparison with adenovirus vectors. Jpn J Pharmacol 2000; 84: 206-12.
15. Wang L, Zhang GM, Feng ZH. Down-regulation of survivin expression reversed multidrug resistance in adriamycin-resistant HL-60/ADR cell line. Acta Pharmacol Sin 2003; 24: 1235-40.